Latest Announcements

Aditya Birla Lifestyle Brands Ltd reported unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue up 11% YoY to Rs. 2046 Cr, EBITDA up 14% YoY to Rs. 327 Cr, and PAT up 21% YoY to Rs. 29 Cr.

Neogen Chemicals Limited has announced its Q1 FY27 earnings conference call transcript, highlighting a strong performance with 34% year-on-year revenue growth, 53% year-on-year EBITDA growth, and 67% year-on-year profit after tax growth. The company has also initiated cost pass-through mechanisms with customers and has received cumulative insurance recoveries of INR 164 crore.

Neogen Chemicals Ltd has announced its Q1FY27 earnings conference call transcript, highlighting a strong performance with 34% year-on-year revenue growth, 53% year-on-year EBITDA growth, and 67% year-on-year profit after tax growth. The company has also initiated cost pass-through mechanisms with customers and has received cumulative insurance recoveries of INR 164 crore.

Sarda Energy & Minerals Ltd. has announced its unaudited financial results for Q1 FY27, with a 9.4% YoY growth in consolidated EBITDA and a 208% YoY growth in PAT. The company reported its highest-ever quarterly PAT of Rs. 478 crore, partly supported by the tariff true-up relating to its 113 MW Sikkim hydropower plant.

Muthoot Finance Ltd has released its investor presentation for Q1 FY 2027, highlighting strong growth driven by sustained momentum, with consolidated loan AUM at ₹191,532 Cr and consolidated profit after tax at ₹2,825 Cr, representing 43% YoY growth and 5% QoQ growth.

Sarda Energy & Minerals Limited has announced its Q1 FY27 results, with a 9.4% YoY growth in consolidated EBITDA and a highest-ever quarterly PAT of Rs. 478 crore. The company's energy business drove growth, contributing nearly 70% of consolidated EBITDA. The company expects to return to its normal operating trajectory from Q2 FY27.

Steel Strips Wheels Limited (SSWL) reports its highest-ever monthly turnover in July 2026, with a 50.72% YoY increase in net turnover and 43.77% YoY growth in gross turnover. The company achieved record sales in all segments, including aluminium, 2 & 3 wheeler, tractor, and exports.

Steel Strips Wheels Ltd reported its highest ever monthly turnover in July 2026, with a 50.72% YoY increase in net turnover and 43.77% YoY growth in gross turnover.

Exide Industries Ltd announced its Q1 FY 2026-27 investor presentation, highlighting its strong brand built over nearly 8 decades, profitable since inception, and ICRA AAA/Stable & A1+ ratings. The company has a portfolio spanning 2.5Ah - 20,200Ah, with a healthy liquidity and strong cash flows. It has a network of 120,000+ touchpoints, 18,000+ villages, and 75+ leading automotive OEMs served. Exide has invested Rs. 4,902 Cr till date and expects revenue generation from its giga factory in FY27.

Vishnu Chemicals Ltd has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The company reported a net profit of ₹3,964.22 lakhs, a 23.5% increase from the previous quarter's net profit of ₹3,222.45 lakhs. The company's revenue from operations was ₹43,340.60 lakhs, a 1.2% increase from the previous quarter's revenue of ₹42,691.55 lakhs.

Amj Land Holdings Limited has submitted its financial results for the quarter ended June 30, 2026, with a total income of Rs. 676.68 lakhs and a profit before tax of Rs. 536.04 lakhs.

Aarti Drugs Ltd has announced its Q1FY27 investor presentation, highlighting a strong operational and financial performance with a 19% YoY revenue growth, 30% YoY EBITDA growth, and 35% YoY PBT growth. The company's API and Speciality Chemicals portfolio saw improved realizations and volume growth, contributing to the robust quarter.

Mangalam Global Enterprise Ltd has announced its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company reported a net profit of ₹752.93 crore, a 23% increase from the previous quarter's net profit of ₹616.08 crore. The results were reviewed and recommended by the Audit Committee and approved by the Board of Directors on August 1, 2026.

Aarti Drugs Limited has released its Q1 FY27 investor presentation, highlighting a strong operational and financial performance driven by volume growth, improved realizations, and disciplined execution. The company reported a 19% YoY increase in net revenue from operations, with EBITDA and PBT margins expanding by 120bps and 120bps, respectively. The company's management commentary attributed the performance to a recovery in the pricing environment and operational efficiencies.

Aarti Drugs Ltd reported its Q1FY27 business and financial performance, with revenue growing 19% YoY to Rs. 703.6 crore, EBITDA increasing 30% YoY to Rs. 96.9 crore, and EBITDA margin expanding 120 bps to 13.8%. The company's CFO & COO, Mr. Adhish Patil, attributed the strong performance to a mix of volume growth and improved realizations across its API & Speciality Chemicals portfolio, as well as disciplined execution.

SMS Pharmaceuticals Ltd has released its Q1FY27 investor presentation, highlighting a 6% YoY revenue growth, sustained EBITDA margin of ~20%, and an 8% YoY PAT growth. The company has completed 4 DMF/CEP filings and is on track to meet its FY27 target of 10 filings. A ₹280 crore capex programme is progressing as planned, and the board has approved an infusion of up to ₹50 crore into its subsidiary SMS Peptides Private Limited.

Aarti Drugs Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue standing at Rs. 703.6 crore, a 19% YoY growth, and EBITDA at Rs. 96.9 crore, a 30% YoY growth.

Vishnu Chemicals Ltd has announced its unaudited consolidated financial results for the first quarter ended June 30, 2026, with a net profit of Rs. 3,964.22 lakhs and a total comprehensive income of Rs. 4,293.65 lakhs.

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation, which includes Q1FY27 financial highlights and key operating metrics. The company's revenue up 6% YoY, driven by diversified growth across high-value APIs, with gross margin remaining above 45% and EBITDA margin sustained at ~20%. The company has completed 4 DMF/CEP filings and is on track to meet FY27 target of 10 DMF/CEP filings. A ₹280 crore capex programme is progressing as planned, and the board has approved infusion of up to ₹50 crore, as a loan, into subsidiary SMS Peptides Private Limited.

SMS Pharmaceuticals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue up 6% YoY, driven by diversified growth across high-value APIs, gross margin above 45%, and EBITDA margin sustained at ~20%. The company has completed 4 DMF/CEP filings and is on track to meet its FY27 target of 10 filings. The ₹280 crore capex programme is progressing as planned, and the company has approved the infusion of up to ₹50 crore as a loan into its subsidiary SMS Pepdes Private Limited.